PeopleBeatingCancer supports an evidence-based integrative approach to cancer care. For most newly diagnosed patients, FDA-approved therapies form the foundation of treatment, while evidence-based complementary therapies may help reduce side effects and improve survivorship.
Click the orange button to the right to learn more.
Chemotherapy-Induced Osteoporosis (Bone Loss): What Every Cancer Survivor Should Know. Chemotherapy can save your life—but it can also weaken your bones. For many cancer survivors, bone loss develops quietly during or after treatment, increasing the risk of osteopenia, osteoporosis, fractures, chronic pain, and disability years later.
The good news is that chemotherapy-induced bone loss is often preventable or treatable when identified early. As a long-term cancer survivor, I believe bone health deserves far more attention than it receives. Many survivors focus on beating cancer, only to discover years later that the therapies that saved them also increased their risk of osteoporosis.
This article explains:
I am a long-term survivor of an incurable blood cancer called multiple myeloma. My research and experience with evidence-based non-conventional therapies is the reason why I have lived in complete remission from my incurable blood cancer since achieving complete remission in early 1999. I have learned that the best way to manage aggressive cancers is to combine the best of conventional and evidence-based non-conventional therapies.
I have come to believe that therapy-induced side effects can be life-threatening while ruining quality of life. Consider therapies shown to reduce possible side effects.
Scroll down the page and post a question or a comment if there’s anything you’d like to know about chemotherapy-induced bone loss.
Good luck,
Yes.
While chemotherapy itself can directly affect bone remodeling, many cancer treatments accelerate bone loss through multiple mechanisms, including:
Cancer treatment-related bone loss can occur much faster than normal aging, making early prevention especially important. ASCO notes that cancer therapy–related bone loss may substantially increase fracture risk in survivors.
Many chemotherapy drugs can:
Examples include:
Many chemotherapy regimens include high-dose corticosteroids.
Examples include:
Steroids:
Multiple myeloma patients are especially vulnerable because dexamethasone is frequently used for months or years.
Aromatase inhibitors
can dramatically reduce estrogen, accelerating bone loss.
Androgen deprivation therapy (ADT)
reduces testosterone and is strongly associated with osteoporosis and fractures.
Patients undergoing autologous or allogeneic stem cell transplantation often experience:
These factors substantially increase osteoporosis risk.
Your risk is higher if you have:
Unfortunately, osteoporosis is often called the “silent disease.”
Many people experience:
Often, the first sign is a broken bone.
Many experts say yes, especially if you have risk factors.
Bone mineral density testing (DEXA) is painless and takes only a few minutes.
ASCO recommends fracture risk assessment for cancer survivors and bone density testing for those at substantial risk.
Ask your doctor if you have:
Strength training remains one of the best-supported lifestyle interventions.
Examples include:
Benefits include:
Walking is excellent.
Even better may include:
The mechanical loading helps stimulate bone remodeling.
Falls cause fractures.
Exercises include:
ASCO specifically recommends combining resistance, endurance, flexibility, and balance training.
Bone is not just calcium.
Protein supports:
Cancer survivors often consume too little protein during treatment.
Vitamin D deficiency is extremely common after cancer therapy.
Vitamin D supports:
ASCO recommends ensuring adequate vitamin D intake (generally 800–1,000 IU/day if dietary intake is insufficient, individualized by your clinician).
Adults generally require about 1,000–1,200 mg/day of calcium from food and supplements combined, depending on age and sex.
Good sources include:
Avoid taking more than necessary, as excessive supplementation may carry risks for some individuals.
Smoking accelerates:
Heavy alcohol use damages bone.
For many survivors, moderation—or abstinence if advised by your physician—is the safest approach.
Patients with established osteoporosis or high fracture risk may benefit from medications.
These include:
Examples:
An alternative antiresorptive therapy.
ASCO recommends bisphosphonates or denosumab for cancer survivors with osteoporosis or sufficiently high fracture risk after assessment.
These medications have potential risks (including rare osteonecrosis of the jaw and atypical femur fractures with long-term use), so treatment decisions should be individualized with your healthcare team.
Bone loss is one of the most overlooked late effects of cancer treatment.
As survivors, we often spend enormous energy getting through chemotherapy, radiation, or transplantation. Yet the consequences of those treatments—such as osteoporosis—can emerge years later and significantly affect independence and quality of life.
The encouraging news is that many of the same habits that lower the risk of cancer recurrence—regular exercise, good nutrition, maintaining muscle mass, avoiding smoking, and keeping vitamin D levels adequate—also support stronger bones. Bone health should be viewed as an essential part of survivorship, not an afterthought.
| Therapy | Evidence | My Rating | Comments |
|---|---|---|---|
| Resistance training | Strong | ★★★★★ | Improves muscle strength, balance, and supports bone health. |
| Weight-bearing exercise | Strong | ★★★★★ | A cornerstone of bone preservation and fracture prevention. |
| Adequate vitamin D | Strong | ★★★★★ | Essential when deficiency is present; monitor blood levels. |
| Adequate calcium intake | Strong | ★★★★★ | Meet, but do not greatly exceed, recommended intake. |
| Balance training | Strong | ★★★★★ | Reduces falls, a major cause of fractures. |
| High-protein diet | Moderate-Strong | ★★★★☆ | Supports bone matrix and muscle mass. |
| Bisphosphonates (high-risk patients) | Strong | ★★★★★ | Effective for reducing fracture risk when indicated. |
| Denosumab (high-risk patients) | Strong | ★★★★★ | Effective alternative to bisphosphonates for appropriate patients. |
| Smoking cessation | Strong | ★★★★★ | Reduces ongoing bone loss and benefits overall health. |
| Limiting alcohol | Moderate | ★★★★☆ | Particularly important for individuals with heavy alcohol use. |
Evidence interpretation: Ratings reflect the strength and consistency of evidence for improving bone health in cancer survivors. Five stars indicate multiple high-quality clinical guidelines and studies supporting the intervention. Lower ratings reflect more limited or less consistent evidence. Lifestyle strategies complement—but do not replace—medical evaluation and treatment when osteoporosis is present.